Intellipharmaceutics International Inc.

IPCIF · OTC
Analyze with AI
11/30/2022
11/30/2021
11/30/2020
11/30/2019
Operating Activities
Net Income-$2,892-$2,892-$5,145-$3,391
Dep. & Amort.$206$206$262$415
Deferred Tax-$6-$6-$94$574
Stock-Based Comp.$0$12$72$265
Change in WC$1,270$1,270$1,423$1,677
Other Non-Cash$84$84$1,081$765
Operating Cash Flow-$1,388-$1,388-$2,461$112
Investing Activities
PP&E Inv.$0$0-$4-$4
Net Acquisitions$482$0$30$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$18$0-$1$29
Investing Cash Flow$500$500$25$25
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$3,069$3,069$28
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$393-$2,869-$38$535
Financing Cash Flow$200$200$3,031$101
Forex Effect$0$0-$25-$101
Net Chg. in Cash-$688-$688$570$137
Supplemental Information
Beg. Cash$772$772$202$65
End Cash$84$84$772$202
Free Cash Flow-$1,388-$1,388-$2,465$108
Intellipharmaceutics International Inc. (IPCIF) Financial Statements & Key Stats | AlphaPilot